Affiliation: | 1. Institute of Cancer Research, London, UK;2. Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, UK;3. Cancer Centre, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK;4. Department of Oncology & Metabolism, The Medical School, Sheffield, UK;5. Additional investigators of the TUXEDO trial are listed in Appendix S1, available online. |